255 related articles for article (PubMed ID: 11577001)
1. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo.
Leng SL; Leeding KS; Gibson PR; Bach LA
Carcinogenesis; 2001 Oct; 22(10):1625-31. PubMed ID: 11577001
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
McBain JA; Eastman A; Nobel CS; Mueller GC
Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium butyrate on expression of members of the IGF-binding protein superfamily in human mammary epithelial cells.
Tsubaki J; Choi WK; Ingermann AR; Twigg SM; Kim HS; Rosenfeld RG; Oh Y
J Endocrinol; 2001 Apr; 169(1):97-110. PubMed ID: 11250651
[TBL] [Abstract][Full Text] [Related]
4. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells.
Chen Z; Clark S; Birkeland M; Sung CM; Lago A; Liu R; Kirkpatrick R; Johanson K; Winkler JD; Hu E
Cancer Lett; 2002 Dec; 188(1-2):127-40. PubMed ID: 12406558
[TBL] [Abstract][Full Text] [Related]
5. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA.
Gálfi P; Neogrády Z; Csordás A
Cancer Lett; 2002 Dec; 188(1-2):141-52. PubMed ID: 12406559
[TBL] [Abstract][Full Text] [Related]
8. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
Schmid C; Ghirlanda-Keller C; Zapf J
Eur J Endocrinol; 2001 Aug; 145(2):213-21. PubMed ID: 11454519
[TBL] [Abstract][Full Text] [Related]
9. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation.
Ewton DZ; Kansra S; Lim S; Friedman E
Int J Cancer; 2002 Apr; 98(5):665-73. PubMed ID: 11920634
[TBL] [Abstract][Full Text] [Related]
11. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
12. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
Kim YH; Park JW; Lee JY; Kwon TK
Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells.
Kim HS; Ingermann AR; Tsubaki J; Twigg SM; Walker GE; Oh Y
Cancer Res; 2004 Mar; 64(6):2229-37. PubMed ID: 15026367
[TBL] [Abstract][Full Text] [Related]
14. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells.
Leng SL; Leeding KS; Whitehead RH; Bach LA
Mol Cell Endocrinol; 2001 Mar; 174(1-2):121-7. PubMed ID: 11306178
[TBL] [Abstract][Full Text] [Related]
16. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis.
Inoue H; Shiraki K; Ohmori S; Sakai T; Deguchi M; Yamanaka T; Okano H; Nakano T
Int J Mol Med; 2002 May; 9(5):521-5. PubMed ID: 11956660
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells.
Hong J; Zhang G; Dong F; Rechler MM
J Biol Chem; 2002 Mar; 277(12):10489-97. PubMed ID: 11784719
[TBL] [Abstract][Full Text] [Related]
19. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II.
Singh P; Dai B; Yallampalli U; Lu X; Schroy PC
Endocrinology; 1996 May; 137(5):1764-74. PubMed ID: 8612513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
